Acelrx Pharmaceuticals shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Acelrx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Acelrx Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acelrx Pharmaceuticals by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $430 | 483 | 0.89 |
| 2025-06-30 | $221 | 483 | 0.46 |
| 2025-03-31 | $374 | 758 | 0.49 |
| 2024-12-31 | $396 | 758 | 0.52 |
| 2024-09-30 | $648 | 758 | 0.86 |
| 2024-06-30 | $689 | 775 | 0.89 |
| 2024-03-31 | $934 | 908 | 1.03 |
| 2023-12-31 | $662 | 901 | 0.74 |
| 2023-09-30 | $518 | 894 | 0.58 |
| 2023-06-30 | $1.1k | 1.0k | 1.11 |
| 2022-12-31 | $2.2k | 975 | 2.26 |